Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study

Vaccine

Volumn 31, Issue 4, 2013, Pages 718-724

  Wang, I Kuan ^a,b   Lin, Cheng Li ^a,c   Chang, Yi Chih ^c   Lin, Po Chang ^a   Liang, Chih Chia ^a   Liu, Yao Lung ^a   Chang, Chiz Tzung ^a   Yen, Tzung Hai ^d,e   Huang, Chiu Ching ^a   Sung, Fung Chang ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Diabetes; Hospitalization; Influenza; Mortality; Vaccine

Indexed keywords

AGED; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MORBIDITY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN; TREATMENT OUTCOME; VACCINATION;

EID: 84871939450     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.017     Document Type: Article

References (28)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. J Am Med Assoc 2004, 292(September (11)):1333-1340.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J Am Med Assoc 2003, 289(January (2)):179-186.
3. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(August (RR-8)):1-62.
4. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(January (1)):4-14.
5. Delamaire M., Maugendre D., Moreno M., Le Goff M.C., Allannic H., Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997, 14(January (1)):29-34.
6. Bertoni A.G., Saydah S., Brancati F.L. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 2001, 24(June (6)):1044-1049.
7. Bouter K.P., Diepersloot R.J., van Romunde L.K., Uitslager R., Masurel N., Hoekstra J.B., et al. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract 1991, 12(April (1)):61-68.
8. Koziel H., Koziel M.J. Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am 1995, 9(March (1)):65-96.
9. Valdez R., Narayan K.M., Geiss L.S., Engelgau M.M. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health 1999, 89(November (11)):1715-1721.
10. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005, 165(February (3)):274-280.
11. Hak E., Nordin J., Wei F., Mullooly J., Poblete S., Strikas R., et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002, 35(August (4)):370-377.
12. Colquhoun A.J., Nicholson K.G., Botha J.L., Raymond N.T. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 1997, 119(December (3)):335-341.
13. Heymann A.D., Shapiro Y., Chodick G., Shalev V., Kokia E., Kramer E., et al. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care 2004, 27(November (11)):2581-2584.
14. Looijmans-Van den Akker I., Verheij T.J., Buskens E., Nichol K.L., Rutten G.E., Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006, 29(August (8)):1771-1776.
15. Lu J.F., Hsiao W.C. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 2003, 22(May-June (3)):77-88.
16. Jian J.W., Chen G.W., Lai C.T., Hsu L.C., Chen P.J., Kuo S.H., et al. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003-2006. J Clin Microbiol 2008, 46(April (4)):1426-1434.
17. Lin J.H., Chiu S.C., Lee C.H., Su Y.J., Tsai H.C., Peng Y.T., et al. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan. J Med Virol 2008, 80(February (2)):316-322.
18. Lin J.H., Chiu S.C., Shaw M.W., Lin Y.C., Lee C.H., Chen H.Y., et al. Characterization of the epidemic influenza B viruses isolated during 2004-2005 season in Taiwan. Virus Res 2007, 124(March (1-2)):204-211.
19. Chang Y.C., Chou Y.J., Liu J.Y., Yeh T.F., Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan - a representative population-based comparative study. J Infect 2012, May.
20. Diepersloot R.J., Bouter K.P., Beyer W.E., Hoekstra J.B., Masurel N. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 1987, 30(June (6)):397-401.
21. Pozzilli P., Gale E.A., Visalli N., Baroni M., Crovari P., Frighi V., et al. The immune response to influenza vaccination in diabetic patients. Diabetologia 1986, 29(December (12)):850-854.
22. Brydak L.B., Machala M. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 2000, 60(July (1)):35-53.
23. Smith S.A., Poland G.A. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000, 23(January (1)):95-108.
24. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997, 46(April (RR-9)):1-25. Centers for Disease Control and Prevention.
25. Estimated influenza vaccination coverage among adults and children-United States, September 1, 2004-January 31, 2005. MMWR Morb Mortal Wkly Rep 2005, 54(April (12)):304-307. Centers for Disease Control and Prevention.
26. Li Y.C. Absence of influenza vaccination among high-risk older adults in Taiwan. BMC Public Health 2010, 10:603.
27. Chou P., Li C.L., Tsai S.T. Epidemiology of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2001, 54(November (Suppl. 1)):S29-S35.
28. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372(August (9636)):398-405.